Zimmer Biomet Holdings (Z1BH34) Fair Value & Analysis
Healthcare · BR · Market cap R$86.4B
Fair value as of: Jul 18, 2026
From 26 valuation models · updated 4 days ago
Fair value updated Jul 18, 2026, revised from R$17.42 to R$16.59 (−4.8%) since Jun 24, 2026. Share price −3.7% over the past month.
Price vs Fair Value (12 months)
12‑month range R$111.45 – R$128.37 · fair‑value band R$11.10 – R$22.78 · the R$111.66 price screens above the R$16.59 fair value. As of Jul 18, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Zimmer Biomet Holdings (Z1BH34) currently trades at R$111.66, while our model-based Fair Value estimate is R$16.59, implying the stock looks roughly 85.1% overvalued today. We read business quality at 58/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Zimmer Biomet Holdings generated revenue of R$8.4B at a net margin of 9.1%. Revenue grew 9.3% year over year. It earns a return on equity of 6.1%. Net debt stands at R$6.9B. Fundamentals as of Jul 18, 2026
Our scenario range runs from R$11.10 (bear case) to R$22.78 (bull case); at R$111.66, the current price sits above that range. The share trades about 13% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -27% fair-value upside, at -85%, Z1BH34 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.
About the company
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Zimmer Biomet Holdings reported revenue of R$8.2B in FY2025 versus R$6.8B in FY2021, a compound +4.8%/yr. Reported net income was R$705M in FY2025, compounding +15.1%/yr from FY2021.
Is Z1BH34 fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $89.17 | $70.59 | -21% |
| Stryker Corporation SYK | $308.84 | $187.83 | -39% |
| Medtronic plc MDTC34 | R$213.40 | R$31.21 | -85% |
| Boston Scientific Corporation B1SX34 | R$229.30 | R$43.33 | -81% |
| Edwards Lifesciences Corporation EWL | €74.82 | €32.56 | -56% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
| DexCom, Inc DXCM | $69.07 | $65.56 | -5% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥144.39 | ¥105.08 | -27% |
| STERIS plc S1TE34 | R$52.14 | R$39.50 | -24% |
| Shanghai United Imaging Healthcare Co 688271 | ¥109.00 | ¥43.60 | -60% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Zimmer Biomet Holdings (Z1BH34) undervalued?
What is the fair value of Z1BH34?
What is the quality score of Z1BH34?
What is the revenue of Zimmer Biomet Holdings (Z1BH34)?
What is the net profit margin of Z1BH34?
Does Zimmer Biomet Holdings pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Zimmer Biomet Holdings analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.